Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis Volume 8, 2007 - Issue 5
Journal homepage
98
Views
25
CrossRef citations to date
0
Altmetric
Original Article

Olfactory ensheathing glia injections in Beijing: Misleading patients with ALS

Sheena Chew Department of Neurology, Eleanor and Lou Gehrig MDA/ALS Research Center,
,
Alexander G. Khandji Department of Radiology (AGK), Columbia University, New York, NY
,
Jacqueline Montes Department of Neurology, Eleanor and Lou Gehrig MDA/ALS Research Center,
,
Hiroshi Mitsumoto Department of Neurology, Eleanor and Lou Gehrig MDA/ALS Research Center,
&
Paul H. Gordon Department of Neurology, Eleanor and Lou Gehrig MDA/ALS Research Center,Correspondence[email protected]
Pages 314-316 | Received 14 Feb 2007, Accepted 11 Apr 2007, Published online: 10 Jul 2009

Citations (25)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Goun Je, Kiandokht Keyhanian & Mehdi Ghasemi. (2021) Overview of stem cells therapy in amyotrophic lateral sclerosis. Neurological Research 43:8, pages 616-632.
Read now
Stephen A. Goutman, Masha G. Savelieff, Stacey A. Sakowski & Eva L. Feldman. (2019) Stem cell treatments for amyotrophic lateral sclerosis: a critical overview of early phase trials. Expert Opinion on Investigational Drugs 28:6, pages 525-543.
Read now
Letizia Mazzini, Daniela Ferrari, Pavle R Andjus, Leonora Buzanska, Roberto Cantello, Fabiola De Marchi, Maurizio Gelati, Rashid Giniatullin, Joel C. Glover, Mariagrazia Grilli, Elena N. Kozlova, Margherita Maioli, Dinko Mitrečić, Augustas Pivoriunas, Rosario Sanchez-Pernaute, Anna Sarnowska & Angelo L. Vescovi. (2018) Advances in stem cell therapy for amyotrophic lateral sclerosis. Expert Opinion on Biological Therapy 18:8, pages 865-881.
Read now
Paul Gordon, Philippe Corcia & Vincent Meininger. (2013) New therapy options for amyotrophic lateral sclerosis. Expert Opinion on Pharmacotherapy 14:14, pages 1907-1917.
Read now
Lidia Cova & Vincenzo Silani. (2010) Amyotrophic lateral sclerosis: applications of stem cells – an update. Stem Cells and Cloning: Advances and Applications 3, pages 145-156.
Read now
Sanne Piepers & Leonard H. van den Berg. (2010) No benefits from experimental treatment with olfactory ensheathing cells in patients with ALS. Amyotrophic Lateral Sclerosis 11:3, pages 328-330.
Read now

Articles from other publishers (19)

Li-peng Zhang, Jun-xiang Liao, Yi-yi Liu, Hong-lang Luo & Wen-jun Zhang. (2023) Potential therapeutic effect of olfactory ensheathing cells in neurological diseases: neurodegenerative diseases and peripheral nerve injuries. Frontiers in Immunology 14.
Crossref
Ting-Jung Lin, Kuang-Chao Cheng, Luo-Yun Wu, Wei-Yu Lai, Thai-Yen Ling, Yung-Che Kuo & Yen-Hua Huang. (2022) Potential of Cellular Therapy for ALS: Current Strategies and Future Prospects. Frontiers in Cell and Developmental Biology 10.
Crossref
S Fadilah Abdul Wahid, Zhe Kang Law, Nor Azimah Ismail & Nai Ming Lai. (2019) Cell-based therapies for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database of Systematic Reviews 2019:12.
Crossref
Paul Wicks & Jamie Heywood. (2016) Getting stem cell patients 'on the grid'. Nature Biotechnology 34:12, pages 1228-1230.
Crossref
S Fadilah Abdul Wahid, Zhe Kang Law, Nor Azimah Ismail, Raymond Azman Ali & Nai Ming Lai. (2016) Cell-based therapies for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database of Systematic Reviews.
Crossref
Kevin S. Chen, Stacey A. Sakowski & Eva L. Feldman. (2016) Intraspinal stem cell transplantation for amyotrophic lateral sclerosis. Annals of Neurology 79:3, pages 342-353.
Crossref
Richard S. Bedlack, Nanette Joyce, Gregory T. Carter, Sabrina Paganoni & Chafic Karam. (2015) Complementary and Alternative Therapies in Amyotrophic Lateral Sclerosis. Neurologic Clinics 33:4, pages 909-936.
Crossref
S Fadilah Abdul Wahid, Zhe Kang Law, Nai Ming Lai, Nor Azimah Ismail & Raymond Azman Ali. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Stephen A. Goutman, Kevin S. Chen & Eva L. Feldman. (2015) Recent Advances and the Future of Stem Cell Therapies in Amyotrophic Lateral Sclerosis. Neurotherapeutics 12:2, pages 428-448.
Crossref
David Choi & Karen Gladwin. (2015) Olfactory Ensheathing Cells: Part II—Source of Cells and Application to Patients. World Neurosurgery 83:2, pages 251-256.
Crossref
Hiroshi Mitsumoto, Benjamin R Brooks & Vincenzo Silani. (2014) Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?. The Lancet Neurology 13:11, pages 1127-1138.
Crossref
J. Simon Lunn, Stacey A. Sakowski & Eva L. Feldman. (2014) Concise Review: Stem Cell Therapies for Amyotrophic Lateral Sclerosis: Recent Advances and Prospects for the Future. STEM CELLS 32:5, pages 1099-1109.
Crossref
Rokhsareh Meamar, Mohammad Hossein Nasr-Esfahani, Seyed Ali Mousavi & Keivan Basiri. (2013) Stem cell therapy in amyotrophic lateral sclerosis. Journal of Clinical Neuroscience 20:12, pages 1659-1663.
Crossref
Syed Ameer Basha Paspala, Aleem Ahmed Khan, Sandeep Vishwakarma & T. V. Ramakrishna Murthy. 2013. Emerging Trends in Cell and Gene Therapy. Emerging Trends in Cell and Gene Therapy 347 371 .
Erin Lavik. 2011. Biomaterials for Tissue Engineering Applications. Biomaterials for Tissue Engineering Applications 489 510 .
Maria Teresa Giordana, Silvia Grifoni, Barbara Votta, Michela Magistrello, Marco Vercellino, Alessia Pellerino, Roberto Navone, Consuelo Valentini, Andrea Calvo & Adriano Chiò. (2009) Neuropathology of Olfactory Ensheathing Cell Transplantation into the Brain of Two Amyotrophic Lateral Sclerosis (ALS) Patients. Brain Pathology 20:4, pages 730-737.
Crossref
JAMIE TALAN. (2009) Stem Cell Clinics Offering Miracle Cures May Be Dangerous to Your Patientsʼ Health. Neurology Today 9:14, pages 25.
Crossref
Jamie Talan. (2009) Warnings About the Risks — and Responsibilities — of Medical Tourism. Neurology Today 9:1, pages 24.
Crossref
Larry Schuster. (2008) Stem Cell Treatments in China. Neurology Today 8:7, pages 24.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.